NCT00959270 Pennington Center Longitudinal Study (PCLS)
| NCT ID | NCT00959270 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Pennington Biomedical Research Center |
| Condition | Health Behaviors |
| Study Type | OBSERVATIONAL |
| Enrollment | 30,000 participants |
| Start Date | 2009-05 |
| Primary Completion | 2050-02 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 30,000 participants in total. It began in 2009-05 with a primary completion date of 2050-02.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to develop a cohort of volunteers that can be studied and followed up into the future for changes in health behaviors and development of health problems.
Eligibility Criteria
Inclusion Criteria: * 18 years or older * volunteer to Participate Exclusion Criteria: * younger than 18 years * Pregnant
Contact & Investigator
Peter Katzmarzyk, PhD
PRINCIPAL INVESTIGATOR
Associate Executive director for Population Science
Frequently Asked Questions
Who can join the NCT00959270 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Health Behaviors. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT00959270 currently recruiting?
Yes, NCT00959270 is actively recruiting participants. Contact the research team at doctors@pbrc.edu for enrollment information.
Where is the NCT00959270 trial being conducted?
This trial is being conducted at Baton Rouge, United States.
Who is sponsoring the NCT00959270 clinical trial?
NCT00959270 is sponsored by Pennington Biomedical Research Center. The principal investigator is Peter Katzmarzyk, PhD at Associate Executive director for Population Science. The trial plans to enroll 30,000 participants.